1. Home
  2. TCBK vs IMCR Comparison

TCBK vs IMCR Comparison

Compare TCBK & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$50.65

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$28.66

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCBK
IMCR
Founded
1975
2008
Country
United States
United Kingdom
Employees
N/A
524
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
TCBK
IMCR
Price
$50.65
$28.66
Analyst Decision
Buy
Buy
Analyst Count
5
10
Target Price
$54.60
$66.33
AVG Volume (30 Days)
73.1K
314.6K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.87%
N/A
EPS Growth
6.94
30.39
EPS
1.04
0.25
Revenue
$53,445,000.00
$249,428,000.00
Revenue This Year
$12.03
$14.57
Revenue Next Year
$4.47
$8.21
P/E Ratio
$48.36
$115.42
Revenue Growth
4.12
43.05
52 Week Low
$38.36
$27.56
52 Week High
$53.18
$40.71

Technical Indicators

Market Signals
Indicator
TCBK
IMCR
Relative Strength Index (RSI) 54.43 46.58
Support Level $48.42 $27.69
Resistance Level $51.09 $31.56
Average True Range (ATR) 0.91 1.09
MACD 0.03 0.06
Stochastic Oscillator 74.30 42.56

Price Performance

Historical Comparison
TCBK
IMCR

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: